뉴스
- Kolon TissueGene Escapes Fourth Limit-Down; Peptron Jumps After Hours[K-Bio Pulse] Kolon TissueGene narrowly avoided a fourth consecutive limit-down close, while Peptron surged in after-hours
- Antrogen Slides on Japan Fears, Hanmi Science Gains[K-Bio Pulse] South Korean biopharmaceutical stocks moved in opposite directions on Tuesday, with Antrogen tumbling to the daily limit on concerns over the commercial potential of its regenerative medicine product...
- BL Pharmtech Hits Daily Limit…Samchundang Pharm Falls[K-bio pulse] Investors in the biopharmaceutical sector continued to show strong interest in BL Pharmtech on July 2 , driving its stock to the daily upper limit.
- Cellid Crashes After-Hours on Phase 3 Failure...Shaperon Dives 25%[K-bio pulse] In the biopharmaceutical sector on Friday, Cellid’s stock surged on expectations for its vaccine clinical trial results, but the shares plunged by the daily limit in after-hours trading followi...